CUHK_CCT00160
2008-03-31
Prospective
N/A
Department of Paediatrics, CUHK
Department of Paediatrics, CUHK
N/A
Lam, Hugh Simon Hung San
Department of Paediatrics, 6/F Clinical Sciences Building, PWH
hshslam@cuhk.edu.hk
Lam, Hugh Simon Hung San
Department of Paediatrics, 6/F Clinical Sciences Building, PWH
hshslam@cuhk.edu.hk
A randomized, double-blind, controlled study of Omegaven for prophylaxis against parenteral nutrition-associated cholestasis (PNAC) in infants requiring prolonged parenteral nutrition
Prevention of PNAC by omegaven
Yes
2008-02-06
Parenteral nutrition-associated cholestasis (PNAC)
Other
parenteral lipid supplement
Omegaven (fish oil-based parenteral lipid supplement)
For as long as subject requires parenteral nutrition (may be 4 months or more)
Intralipid (soy-based parenteral lipid supplement)
Inclusion criteria: (i) newborn infants without PNAC at the time of randomization; (ii) anatomical/functional short bowel syndrome or expected to be nil by mouth for > 4 weeks; (iii) informed parenteral consent
Exclusion criteria: (i) major congenital or lethal chromosomal abnormalities; (ii) multiorgan failure and imminent death; (iii) cholestatic jaundice secondary to known cause other than parenteral nutrition associated cholestasis (PNAC).
Randomized
Active
Double-blind
Parallel
2008-04-30
26
Recruiting
Development of PNAC over 4 months
Infant growth; blood lipid profile; coagulation status; episodes of late-onset infection over 4 months.
2020-04-26
Yes
N/A
|
|
|
|
|
---|---|---|---|---|
No documents yet. |